Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thrombectomy | 13 | 2022 | 583 | 2.940 |
Why?
|
Stroke | 26 | 2022 | 8730 | 2.610 |
Why?
|
Brain Ischemia | 12 | 2022 | 3150 | 2.010 |
Why?
|
Angiotensin I | 5 | 2015 | 58 | 1.860 |
Why?
|
Endovascular Procedures | 9 | 2022 | 1791 | 1.790 |
Why?
|
Mucopolysaccharidosis II | 1 | 2021 | 29 | 0.940 |
Why?
|
Vertebral Artery | 1 | 2021 | 188 | 0.860 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 2021 | 118 | 0.850 |
Why?
|
Cerebral Infarction | 4 | 2022 | 1018 | 0.780 |
Why?
|
Cerebral Angiography | 3 | 2021 | 1365 | 0.760 |
Why?
|
Brain Infarction | 2 | 2020 | 305 | 0.750 |
Why?
|
Peptide Fragments | 6 | 2015 | 5167 | 0.740 |
Why?
|
Endothelin-1 | 5 | 2015 | 299 | 0.730 |
Why?
|
Leukoencephalopathies | 1 | 2020 | 244 | 0.690 |
Why?
|
Infarction, Middle Cerebral Artery | 4 | 2015 | 436 | 0.690 |
Why?
|
Cerebral Arteries | 1 | 2019 | 496 | 0.640 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2021 | 2544 | 0.590 |
Why?
|
Cerebral Amyloid Angiopathy | 1 | 2020 | 704 | 0.530 |
Why?
|
Nerve Regeneration | 1 | 2020 | 790 | 0.520 |
Why?
|
Patient Transfer | 3 | 2021 | 737 | 0.490 |
Why?
|
Middle Cerebral Artery | 2 | 2013 | 252 | 0.480 |
Why?
|
Receptors, G-Protein-Coupled | 4 | 2015 | 1185 | 0.420 |
Why?
|
Recovery of Function | 3 | 2020 | 2965 | 0.420 |
Why?
|
Peptidyl-Dipeptidase A | 4 | 2016 | 332 | 0.410 |
Why?
|
Neuroprotective Agents | 3 | 2015 | 1015 | 0.410 |
Why?
|
Renin-Angiotensin System | 2 | 2015 | 744 | 0.400 |
Why?
|
Reperfusion | 2 | 2020 | 269 | 0.400 |
Why?
|
Vasodilator Agents | 1 | 2014 | 1004 | 0.380 |
Why?
|
Embolization, Therapeutic | 4 | 2021 | 1314 | 0.380 |
Why?
|
Collateral Circulation | 2 | 2021 | 313 | 0.370 |
Why?
|
Microglia | 2 | 2013 | 1145 | 0.360 |
Why?
|
Skull | 1 | 2013 | 796 | 0.350 |
Why?
|
Intracranial Aneurysm | 3 | 2021 | 1196 | 0.350 |
Why?
|
Treatment Outcome | 17 | 2022 | 60991 | 0.340 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 4208 | 0.320 |
Why?
|
Decompression, Surgical | 2 | 2021 | 567 | 0.300 |
Why?
|
Proto-Oncogene Proteins | 4 | 2015 | 4716 | 0.280 |
Why?
|
Time Factors | 6 | 2021 | 42271 | 0.260 |
Why?
|
Retrospective Studies | 13 | 2022 | 67320 | 0.240 |
Why?
|
Aged | 18 | 2022 | 162271 | 0.240 |
Why?
|
Brain | 2 | 2020 | 24202 | 0.240 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 2256 | 0.240 |
Why?
|
Middle Aged | 22 | 2022 | 216468 | 0.230 |
Why?
|
Carotid Artery, Internal, Dissection | 1 | 2020 | 39 | 0.220 |
Why?
|
Peptides | 1 | 2014 | 4537 | 0.210 |
Why?
|
Humans | 39 | 2022 | 686663 | 0.210 |
Why?
|
Male | 27 | 2022 | 352465 | 0.210 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2020 | 125 | 0.200 |
Why?
|
Aged, 80 and over | 11 | 2022 | 59331 | 0.200 |
Why?
|
Cerebral Cortex | 2 | 2015 | 5761 | 0.200 |
Why?
|
Cerebrovascular Circulation | 4 | 2020 | 2701 | 0.200 |
Why?
|
Aneurysm, Ruptured | 2 | 2021 | 439 | 0.200 |
Why?
|
Paralysis | 1 | 2020 | 225 | 0.200 |
Why?
|
Thrombolytic Therapy | 2 | 2020 | 2152 | 0.190 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2021 | 155 | 0.190 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2020 | 292 | 0.180 |
Why?
|
Female | 23 | 2022 | 375459 | 0.180 |
Why?
|
Diminazene | 2 | 2015 | 3 | 0.180 |
Why?
|
Intracranial Embolism | 1 | 2020 | 212 | 0.180 |
Why?
|
Tanzania | 2 | 2019 | 1123 | 0.180 |
Why?
|
Fibrinolytic Agents | 2 | 2019 | 2132 | 0.180 |
Why?
|
Infusions, Intraventricular | 2 | 2015 | 34 | 0.170 |
Why?
|
Bayes Theorem | 2 | 2022 | 1848 | 0.170 |
Why?
|
Corpus Striatum | 2 | 2015 | 1275 | 0.170 |
Why?
|
Magnetic Resonance Imaging | 3 | 2021 | 33186 | 0.170 |
Why?
|
Rats, Sprague-Dawley | 6 | 2015 | 8707 | 0.170 |
Why?
|
Nitric Oxide Synthase Type II | 3 | 2014 | 569 | 0.160 |
Why?
|
Cohort Studies | 6 | 2022 | 38732 | 0.160 |
Why?
|
History, 19th Century | 1 | 2019 | 746 | 0.160 |
Why?
|
Rats | 7 | 2015 | 25307 | 0.150 |
Why?
|
Brain Stem | 1 | 2021 | 832 | 0.150 |
Why?
|
Arterial Occlusive Diseases | 1 | 2020 | 858 | 0.150 |
Why?
|
Thalamus | 1 | 2021 | 952 | 0.140 |
Why?
|
Angiotensin II Type 2 Receptor Blockers | 1 | 2014 | 10 | 0.140 |
Why?
|
Stents | 3 | 2021 | 3318 | 0.140 |
Why?
|
Hypertension | 1 | 2013 | 7941 | 0.140 |
Why?
|
Cervical Vertebrae | 1 | 2020 | 896 | 0.140 |
Why?
|
Triage | 2 | 2021 | 932 | 0.140 |
Why?
|
Deglutition Disorders | 1 | 2019 | 554 | 0.130 |
Why?
|
Carotid Stenosis | 1 | 2020 | 831 | 0.130 |
Why?
|
Spine | 1 | 2021 | 1059 | 0.130 |
Why?
|
Rats, Inbred SHR | 1 | 2013 | 212 | 0.130 |
Why?
|
Predictive Value of Tests | 2 | 2020 | 15407 | 0.130 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2013 | 242 | 0.130 |
Why?
|
Intracranial Hemorrhages | 1 | 2019 | 783 | 0.120 |
Why?
|
Corticosterone | 1 | 2013 | 325 | 0.120 |
Why?
|
Neurogenesis | 1 | 2020 | 845 | 0.120 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2013 | 254 | 0.120 |
Why?
|
Disease Progression | 2 | 2021 | 13204 | 0.120 |
Why?
|
Databases, Factual | 4 | 2021 | 7865 | 0.120 |
Why?
|
History, 21st Century | 1 | 2019 | 1594 | 0.120 |
Why?
|
Animals | 12 | 2020 | 170849 | 0.120 |
Why?
|
Recurrence | 2 | 2020 | 8198 | 0.110 |
Why?
|
Disability Evaluation | 1 | 2019 | 1821 | 0.110 |
Why?
|
Disabled Persons | 1 | 2020 | 1097 | 0.110 |
Why?
|
Tissue Plasminogen Activator | 1 | 2018 | 1307 | 0.110 |
Why?
|
Sex Characteristics | 1 | 2021 | 2445 | 0.110 |
Why?
|
History, 20th Century | 1 | 2019 | 2878 | 0.100 |
Why?
|
Urban Population | 1 | 2019 | 2144 | 0.100 |
Why?
|
Prospective Studies | 5 | 2021 | 49071 | 0.100 |
Why?
|
Mice, Inbred Strains | 1 | 2013 | 2000 | 0.100 |
Why?
|
Dementia | 1 | 2021 | 1984 | 0.090 |
Why?
|
Patient Admission | 1 | 2017 | 1410 | 0.090 |
Why?
|
Antihypertensive Agents | 1 | 2019 | 2006 | 0.090 |
Why?
|
Risk Factors | 6 | 2021 | 69278 | 0.090 |
Why?
|
alpha-Synuclein | 1 | 2014 | 632 | 0.090 |
Why?
|
Neurosurgical Procedures | 1 | 2020 | 1888 | 0.090 |
Why?
|
Reconstructive Surgical Procedures | 1 | 2020 | 2096 | 0.090 |
Why?
|
Central Nervous System | 1 | 2014 | 1216 | 0.080 |
Why?
|
Aspirin | 1 | 2019 | 3142 | 0.080 |
Why?
|
Disease Models, Animal | 4 | 2015 | 18495 | 0.080 |
Why?
|
Palliative Care | 1 | 2021 | 3093 | 0.080 |
Why?
|
Biopsy | 1 | 2019 | 6849 | 0.080 |
Why?
|
Telemedicine | 1 | 2021 | 2270 | 0.070 |
Why?
|
African Americans | 1 | 2021 | 5144 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3016 | 0.070 |
Why?
|
Nitric Oxide | 1 | 2013 | 2054 | 0.070 |
Why?
|
Physicians | 1 | 2021 | 4060 | 0.070 |
Why?
|
Phenotype | 2 | 2019 | 16091 | 0.060 |
Why?
|
Motor Activity | 1 | 2014 | 2817 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2021 | 16227 | 0.060 |
Why?
|
Body Weight | 1 | 2013 | 4804 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2020 | 4466 | 0.060 |
Why?
|
Pandemics | 1 | 2021 | 5859 | 0.060 |
Why?
|
Prognosis | 2 | 2020 | 28923 | 0.060 |
Why?
|
Blood Pressure | 2 | 2016 | 8529 | 0.050 |
Why?
|
Inflammation | 1 | 2020 | 9617 | 0.050 |
Why?
|
Angiography, Digital Subtraction | 1 | 2021 | 379 | 0.050 |
Why?
|
Heart | 1 | 2013 | 4233 | 0.050 |
Why?
|
Angiotensin II | 2 | 2015 | 961 | 0.050 |
Why?
|
Cerebral Revascularization | 1 | 2021 | 208 | 0.050 |
Why?
|
Patient Rights | 1 | 2020 | 129 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 2013 | 4716 | 0.050 |
Why?
|
Diskectomy | 1 | 2020 | 169 | 0.050 |
Why?
|
Depression | 1 | 2018 | 6805 | 0.050 |
Why?
|
Bioethical Issues | 1 | 2020 | 129 | 0.050 |
Why?
|
Risk Assessment | 1 | 2020 | 23739 | 0.050 |
Why?
|
Kidney | 1 | 2013 | 6744 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2020 | 15083 | 0.040 |
Why?
|
Imidazoles | 2 | 2015 | 1288 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17071 | 0.040 |
Why?
|
Mice, Knockout | 1 | 2013 | 15597 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2021 | 1480 | 0.040 |
Why?
|
Enzyme Activation | 2 | 2015 | 3969 | 0.040 |
Why?
|
Canada | 1 | 2021 | 1905 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2013 | 20620 | 0.040 |
Why?
|
Ischemic Attack, Transient | 1 | 2020 | 881 | 0.040 |
Why?
|
Leucine | 1 | 2015 | 596 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 12680 | 0.030 |
Why?
|
Systole | 1 | 2016 | 1008 | 0.030 |
Why?
|
ADAM Proteins | 1 | 2015 | 274 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 2014 | 561 | 0.030 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2014 | 529 | 0.030 |
Why?
|
Information Dissemination | 1 | 2021 | 1095 | 0.030 |
Why?
|
Spinal Fusion | 1 | 2020 | 1025 | 0.030 |
Why?
|
Radiographic Image Enhancement | 1 | 2017 | 959 | 0.030 |
Why?
|
Peroxidase | 1 | 2014 | 656 | 0.030 |
Why?
|
Random Allocation | 1 | 2015 | 2507 | 0.030 |
Why?
|
Mice | 2 | 2014 | 80803 | 0.020 |
Why?
|
Thiophenes | 1 | 2014 | 601 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 2930 | 0.020 |
Why?
|
Social Support | 1 | 2018 | 2088 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10926 | 0.020 |
Why?
|
Anticoagulants | 1 | 2021 | 4173 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 6088 | 0.020 |
Why?
|
Brain Mapping | 1 | 2021 | 6421 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 13603 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2020 | 2972 | 0.020 |
Why?
|
Sulfonamides | 1 | 2014 | 1961 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 8926 | 0.020 |
Why?
|
Age Factors | 1 | 2021 | 19295 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8070 | 0.020 |
Why?
|
Adult | 3 | 2021 | 211400 | 0.010 |
Why?
|
Pyridines | 1 | 2014 | 2843 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2014 | 10094 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 11616 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10766 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39737 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 13469 | 0.010 |
Why?
|
Cytokines | 1 | 2014 | 7147 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 23439 | 0.010 |
Why?
|
United States | 1 | 2021 | 65579 | 0.010 |
Why?
|
Signal Transduction | 1 | 2015 | 24351 | 0.010 |
Why?
|
Concepts
(183)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(63)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_